Cascade, MD, United States of America

Thomas J Palys

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Arch Chemicals, Inc., USA as Represented by Secretary of the Navy. Active years: 2005-2014.

USPTO Granted Patents = 5 

% Patents Active = 40.0


Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • Berlin, CT (US) (2008 - 2012)
  • Cascade, MD (US) (2005 - 2014)

Company Filing History:


Years Active: 2005-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Hello! I'm glad to assist you with the article about inventor Thomas J Palys.

Title: Inventor Spotlight - Thomas J Palys

Introduction: Thomas J Palys, a prolific inventor based in Cascade, MD, has made significant contributions to the field of antimicrobial compositions.

Latest Patents: Thomas J Palys holds five patents, including two groundbreaking innovations:

1. "Pyrithione biocides enhanced by zinc metal ions and organic amines": A stable, soluble antimicrobial composition concentrate effective in controlling the growth of microorganisms or biofilms.

2. "Pyrithione biocides enhanced by silver, copper, or zinc ions": An antimicrobial composition with enhanced biocidal effects against various microorganisms or biofilms, applicable in a wide range of products.

Career Highlights: Palys has worked with industry giants such as Arch Chemicals, Inc. and The United States of America, contributing his expertise in developing antimicrobial solutions.

Collaborations: During his career, Thomas J Palys has collaborated with notable professionals including Michelle L Rioux and Diana T Ciccognani, further enriching his innovative endeavors.

Conclusion: Thomas J Palys' innovative work in antimicrobial compositions has paved the way for advancements in controlling the growth of microorganisms across diverse industries. His dedication to creating effective solutions showcases his commitment to driving innovation forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…